Delivery Order SPE2DB20D1100-SPE2DB24FB7A7
Award Date
5/9/24
Potential Completion Date
5/10/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,073.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of March 1, 2024. This is a firm-fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,310.68 for the supply of GEMTESA 75 MG TABLET 30S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,427.96 for the supply of the pharmaceutical product GEMTESA 75 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that provides logistics, acquisitions, and technical services to the U.S. military. The contract has an ultimate completion date of July 21, 2023 and is a firm fixed-price delivery order,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $69,820.60 and is a delivery order for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $41,063.25. The award is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a period of performance through March 1, 2024. The parent company, Cencora, Inc., doing business as Amerisourcebergen, holds a significant IDC with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,815.99 firm-fixed-price delivery order is for GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 18, 2023 and was awarded on August 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,895.23 fixed-price delivery order is for the pharmaceutical product GEMTESA 75 MG TABLET 90S, with a performance period ending on November 17, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle...
This federal contract award, valued at $1,614.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of January 24, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp is a subsidiary of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,443.64, is a delivery order for the pharmaceutical product GEMTESA 75 MG TABLET 90S. The award does not have a set-aside designation, indicating it was competitively bid. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,440.71, is for the delivery of the medication GEMTESA 75 MG TABLET 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 21, 2024. The contract was awarded on June 20, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...